Moshe Mendelson
Optometrist · Sunnyvale, CANPI 1366443277
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (43.4%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. Johnson & Johnson Vision Care, Inc. accounts for 80.6% of it on its own, with 20 other manufacturers making up the rest. Reporting peaked in 2022 at $8,570 and has fallen 87.8% since, to $1,046 in 2025. Among optometrist clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 182 payments — averaging $147.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson Vision Care, Inc.$22K
- Johnson & Johnson Surgical Vision, Inc.$1K
- Sun Pharmaceutical Industries Inc.$756
- Coopervision Inc.$650
- Alcon$384
- Visioneering Technologies, Inc.$341
- plus $2K from 15 others
Across 4 payments — averaging $3870.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bausch Health US, LLC$15K
What the payments were for
- Consulting fees$11,61343%
- Speaking & faculty fees$8,25031%
- Travel & lodging$1,7897%
- Food & beverage$5,11419%
- Gifts$170%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson Vision Care, Inc. | 57 | $21,586 |
| Johnson & Johnson Surgical Vision, Inc. | 2 | $1,041 |
| Sun Pharmaceutical Industries Inc. | 29 | $756 |
| Coopervision Inc. | 6 | $650 |
| Alcon | 12 | $384 |
| Visioneering Technologies, Inc. | 3 | $341 |
| Lumenis BE Inc | 2 | $339 |
| Novartis | 17 | $306 |
| Shire North American Group Inc | 9 | $304 |
| Biotissue Holdings Inc. | 8 | $218 |
| Oyster Point Pharma, Inc. | 2 | $212 |
| Kala Pharmaceuticals, Inc. | 13 | $183 |
| Bausch & Lomb Americas Inc. | 7 | $132 |
| Dompe US, Inc. | 4 | $116 |
| AbbVie(2 entities) | 4 | $90 |
| Amgen | 2 | $37 |
| Lumenis, Inc | 1 | $25 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $22 |
| Tarsus Pharmaceuticals, Inc. | 1 | $18 |
| Carl Zeiss Meditec, Inc. | 1 | $17 |
| ABB Con-cise Optical Group LLC | 1 | $5 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Acuvue$16,602
- MiSight Contact Lens$500
- CEQUA$350
- optilight$190
- Hydrus Microstent$159
- M22$149
- XIIDRA$125
- TYRVAYA$123
How this compares
$26,782 in reported general payments places this provider in the 95th percentile of 6,778 optometrist providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Latanoprost | 28 | $433 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Sunnyvale
- Steve YoelinNewport Beach$4.1M
- Matthew GellerSpring Valley$3.5M
- Melissa EricksonDavis$522K
- Omid KhodaiLake Forest$499K
- Jason TuSan Diego$351K
- Scott SchachterPismo Beach$312K
- Alicia LauSan Diego$300K
- Vin DangBakersfield$284K
- Steven FerrucciSepulveda$272K
- Katie ChuRosemead$271K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.